Market Tracker

08/23 3:44am ET

Impax Laboratories Inc (NASDAQ:IPXL)

18.55
Delayed Data
As of Aug 22
 +0.10 / +0.54%
Today’s Change
7.75
Today|||52-Week Range
27.29
+40.00%
Year-to-Date

Today’s Trading

Previous close18.45
Today’s open18.45
Day’s range18.25 - 18.60
Volume818,887
Average volume (3 months)1,824,593
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-39.82%
Earnings growth (next 5 years)+6.21%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.52+4.31%
TBPHTheravance Biopharma...+0.95+3.58%
EBSEmergent BioSolution...+0.97+2.78%
PCRXPacira Pharmaceutica...+0.10+0.28%
Data as of 4:02pm ET, 08/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.20
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts